Berridge, Craig W <br/><br/>
Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.  [electronic resource] 

 -  Biological psychiatry  Nov 2006 
 - 1111-20 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0006-3223 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2006.04.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Uptake Inhibitors--blood<br/>Analysis of Variance<br/>Animals<br/>Behavior, Animal<br/>Brain Chemistry--drug effects<br/>Catecholamines--metabolism<br/>Chromatography, High Pressure Liquid--methods<br/>Cognition--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Administration Routes<br/>Electroencephalography--methods<br/>Electromyography--methods<br/>Male<br/>Memory, Short-Term--drug effects<br/>Methylphenidate--blood<br/>Microdialysis--methods<br/>Motor Activity--drug effects<br/>Prefrontal Cortex--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Detection, Psychological--drug effects<br/>Sleep--drug effects<br/>Vision, Ocular--drug effects